Noninvasive monitoring and tracking of muscle stem cell transplants

Transplantation

Volumn 78, Issue 11, 2004, Pages 1626-1633

  Cahill, Kevin S ^a   Gaidosh, Gabriel ^a   Huard, Johnny ^b   Silver, Xeve ^a   Byrne, Barry J ^a   Walter, Glenn A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dystrophy; Myopathies; Nuclear magnetic resonance; Stem cell therapy

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; POLYCATION; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL DIFFERENTIATION; CELL LABELING; CELL MATURATION; CELL MIGRATION; COMPLEX FORMATION; DIAGNOSTIC ACCURACY; DUCHENNE MUSCULAR DYSTROPHY; ENDOSOME; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROSCOPY; MOUSE; MULTIPOTENT STEM CELL; MUSCLE CELL; MYOTUBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; THREE DIMENSIONAL IMAGING;

ANIMALS; ARTERIES; CELL DEATH; CELL DIFFERENTIATION; CELLS, CULTURED; MAGNETIC RESONANCE IMAGING; MICE; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; STEM CELL TRANSPLANTATION;

EID: 10644236974     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000145528.51525.8B     Document Type: Article

References (24)

1. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687.
2. Cossu G, Mavilio F. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J Clin Invest 2000; 105: 1669.
3. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002; 9: 642.
4. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301: 487.
5. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93.
6. Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol 2001; 29: 1237.
7. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 1999; 212: 609.
8. Wu JC, Chen IY, Sundaresan G, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 2003; 108: 1302.
9. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation 2003; 107: 1092.
10. Weissleder R, Cheng HC, Bogdanova A, et al. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997; 7: 258.
11. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19: 1141.
12. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999; 96: 15256.
13. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410.
14. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (PDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol 2002; 9(Suppl 2): S484.
15. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000; 150: 1085.
16. Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 1971; 40: 450.
17. Bulte JW, Miller GF, Vymazal J, et al. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med 1997; 37: 530.
18. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13: 661.
19. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319.
20. Lollo CP, Banaszczyk MG, Mullen PM, et al. Poly-L-lysine-based gene delivery systems. Synthesis, purification, and application. Methods Mol Med 2002; 69: 1.
21. Yuasa K, Ishii A, Miyagoe Y, et al. [Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector]. Nippon Rinsho 1997; 55: 3148.
22. Laurent N, Wattiaux-De Coninck S, Mihaylova E, et al. Uptake by rat liver and intracellular fate of plasmid DNA complexed with poly-L-lysine or poly-D-lysine. FEBS Lett 1999; 443: 61.
23. Torrente Y, Camirand G, Pisati F, et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 2003; 162: 511.
24. Torrente Y, Tremblay JP, Pisati F, et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 2001; 152: 335.